| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ELIQUIS | 202155 | 001 | NDA | APIXABAN | TABLET;ORAL | 2.5MG | Yes | No | 2012/12/28 | 2012/12/28 | BRISTOL MYERS SQUIBB | Prescription |
| ELIQUIS | 202155 | 002 | NDA | APIXABAN | TABLET;ORAL | 5MG | Yes | Yes | 2012/12/28 | 2012/12/28 | BRISTOL MYERS SQUIBB | Prescription |
| ELIQUIS | 202155 | 003 | NDA | APIXABAN | TABLET, FOR SUSPENSION;ORAL | 0.5MG | Yes | Yes | 2012/12/28 | 2025/04/17 | BRISTOL MYERS SQUIBB | Prescription |
| ELIQUIS SPRINKLE | 220073 | 001 | NDA | APIXABAN | FOR SUSPENSION;ORAL | 0.15MG | Yes | Yes | 2025/04/17 | 2025/04/17 | BRISTOL | Prescription |
| ELIQUIS | 220073 | 002 | NDA | APIXABAN | TABLET;ORAL | 5MG | No | No | 2025/04/17 | -- | BRISTOL | Prescription |
| ELIQUIS | 220073 | 003 | NDA | APIXABAN | TABLET;ORAL | 0.5MG | No | No | 2025/04/17 | -- | BRISTOL | Prescription |
| ELIQUIS | 220073 | 004 | NDA | APIXABAN | SUSPENSION;ORAL | 0.15MG | No | No | 2025/04/17 | -- | BRISTOL | Prescription |